Answers are grounded in this paper and cite their sources.
This research reveals an amino-functionalized ionic liquid catalyst for efficient transesterification, suggesting significant enhancements over conventional catalytic systems.
This study reports the development of a novel amino‐functionalized ionic liquid catalyst, namely 1‐butyl‐3‐methylimidazolium amino triazole ([EMIM]ATZ), for the efficient and sustainable synthesis of ethyl methyl carbonate (EMC) via transesterification of dimethyl carbonate (DMC) and ethanol (C 2 H 5 OH) at room temperature. Addressing the limitations of conventional catalytic systems that require elevated temperatures (> 75°C), [EMIM]ATZ achieves 62% DMC conversion and 56% EMC yield within 8 h under room temperature (25°C), while conventional ionic liquids ([EMIM]Cl, [EMIM]BF 4 , [EMIM]PF 6 etc.) showed almost no activity at room temperature. The catalyst's superior activity stems from its strong basicity (pH ≈ 9.2) and enhanced CO 2 absorption capacity (200 mg·g −1 ), which synergistically activate C 2 H 5 OH and stabilize reaction intermediates. Structural characterization via FTIR and thermogravimetric analysis (TGA) confirmed the catalyst's thermal stability and recyclability, with no significant degradation observed over five reuse cycles (89% activity retention). In addition, the ionic liquid was also able to catalyze the synthesis of methyl propyl carbonate (PMC) and methyl butyl carbonate (BMC) at room temperature.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: